DERL1 and urinary bladder cancer: Immunohistochemistry showed that non-neoplastic bladder urothelium was negative for Derlin-1 protein, while Derlin-1 was upregulated in 58 of 150 bladder cancer specimens and correlated with muscle invasive phenotype (T2-T4).